Wang W, Nema S, Teagarden D
Research in aging mouse models shows that MOTS-c administration suppresses SASP markers and reduces the burden of senescent cells in metabolically active tissues [2]
They are provided for research context only: Sikiric P, et al
However, both compounds individually cause: Nausea (60-80% of users at higher doses) Vomiting (20-35%) Diarrhea (25-40%) Injection site reactions (15-25%) Potential pancreatitis (rare but serious) Combining these compounds could theoretically amplify these effects, though the actual incidence and severity remain unstudied
The patient profile that benefits most at our clinic looks like this: Soft tissue injury that has stalled: The patient has completed physical therapy, has no surgical indication, but is still symptomatic at 8 to 12 weeks
That peptide might have cost $30, $50, or $100